Point of Care is a relatively novel medical practice that has been gaining momentum in the developed countries over the last twenty years.
Point of Care endows the healthcare professional to assess directly and reliably certain diagnostic variables of the patient at the point where such assessments are needed. Practicing Point of Care medicine does not require any special laboratory instrumentation other than using the devices themselves. Therefore Point of Care can be applied to any patient at any location and time point (e.g. at the practice, in the ambulance, on the field.).
Point of Care is literally a platform of diagnostic products that usually exploit the high affinity and specificity of the antibody-antigen reaction. All our Point of Care rapid diagnostic products have been approved by the US FDA, as well as the European Regulatory Authorities. Moreover, Point of Care products enjoy a prominent role in and diagnostic algorithms and therapeutic formularies of many developed countries. For example, the US Center of Disease Control and Prevention (CDC) or the UK National Institute of Clinical Excellence strongly supports the wide usage of Point of Care devices in medicine.
Applying Point of Care has revolutionized medical practice in the Western world leading to considerable savings in healthcare resources. Point of Care allows targeted diagnosis and treatment on three different levels.
Diagnosis
Point of Care facilitates rapid and reliable diagnosis of key markers.
Treatment Evaluation
Point of Care allows for patient or therapeutic treatment monitoring.
Prevention
Point of Care facilitates patient evaluation and monitoring of diagnostic markers that can help predict/prevent the development of malignant diseases like colorectal or prostate cancer.